Lec 2 Commercial Biotechnology

• Translational science bridges basic research and practical applications, aiming to convert lab findings into real-world solutions, often described as moving from "bench to bedside."

Key Steps in Translational Science

1. Novel Idea: Addressing societal problems.

2. From Lab to Application: Demonstrating effects in models translate to humans through clinical trials.

3. Getting the Product to People: Convincing clinicians and ensuring cost-effectiveness.

Phases of Translational Health Research

• Begins with basic science (T0) and ends with global societal benefit (T4).

1. T0 - Basic Science/Preclinical Work: Cell and animal studies.

2. T1 - Translation to Humans: Proof-of-concept and Phase 1 clinical trials.

3. T2 - Clinical Trials (Phases 2 and 3): Trials with patients.

4. T3 - Community-Based Impact: Community impact.

5. T4 - Global/Societal Impact: Global health benefits.

• The entire process (T0-T4) takes approximately 15-20 years

Biotechnology

• Biotechnology applies scientific knowledge to solve problems.

AlphaFold AI

• AlphaFold AI predicts protein folding, aiding understanding of molecular interactions crucial for drug development.

Applications of AI in Biotechnology

1. Personalized Medicine: Customized therapies based on genetics.

2. Drug Discovery: Efficient modeling to reduce animal and human trials.

3. Synthetic Biology: AI to generate new microorganisms for drug production.

4. Regenerative Medicine: Identifying optimal cell types and predicting cell behavior.

5. Data Integration: Comprehensive analysis of biological and medical data.

Commercializing Biotechnology

• Commercialization brings ideas to market, requiring collaboration and funding.

Assessing Commercialization Potential

1. Technology: Originality and market potential.

2. Funding: Ability to secure funding.

3. Legal Protection (Intellectual Property): Ensuring return on investment.

Key Considerations for Commercialization

• Originality: Novel and scalable ideas.

• Funding: Financial support for development.

• Intellectual Property: Protecting ideas for exclusive rights.

• Market Potential: Identifying customers and assessing market viability.

• Competition: Assessing and surpassing competitors.

• Regulatory Hurdles: Navigating regulatory approvals.

• Business Plan: Viable plan for manufacturing, distribution, and sales.

• Communication: Effective communication with stakeholders.

• Ethics: Considering ethical implications.

• Risk Mitigation: Minimizing technical and financial risks.

Funding Sources at Different Stages

1. Early Stage (Basic Science): Government grants and philanthropic support.

2. Later Stage (Commercialization): Venture capitalists.

Government Funding Schemes (Australia)

1. Australian Research Council (ARC): Funds non-medical research.

2. National Health and Medical Research Council (NHMRC): Funds health and medical research.

3. Medical Research Future Fund (MRFF): Focuses on improving patient outcomes.

Venture Capitalists

• Early stage: Higher risk tolerance. Late stage: Lower risk tolerance.

Ecosystem for Commercialization

• Requires buy-in from funders, venture capitalists, and regulatory bodies.

Commercialization Support at UNSW

• UNSW Founders is the accelerator at UNSW, offering funding and mentoring.

Intellectual Property (IP)

• IP protects inventions, allowing exclusive use and commercialization.

Types of IP Protections

1. Patents: Protect inventions and processes.

2. Trademarks: Protect logos and branding.

3. Copyright: Protects words and images.

Patents

• Patents grant legal rights for 20 years if the idea is novel, inventive, and useful.

Importance of Patents in Biotechnology

• Protects biotechnology companies and attracts funders.

Patent Infringement

• Occurs when a patented invention is used without permission; the inventor can sue.

Ethics of Commercializing Biotechnology

• Economic incentives may disfavor developing cures in favor of managing symptoms for profit.